abstract |
The invention provides a method of treating an autoimmune disease in a subject by administering an interferon antagonist and an antagonist ligand Flt3 ligand (FLt3L). The invention also provides compositions comprising one or more interferon antagonists, and one or more Flt3L antagonists in an in vitro assay to determine the risk of a subject to develop an autoimmune disease and kits for use among others with the assay. |